Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
2 CALLS ON FILE
SMMT
— Summit Therapeutics Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
FEB 24, 2026
REVENUE
$0
EPS
-$0.29
+6.5%
FREE CASH FLOW
-$75.8M
-9.4%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 2
OLDER CALL →